Cited by 141Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and TreatmentsLiver Disease and Transplantation

Diminished survival in asymptomatic primary biliary cirrhosis

Open access
Balasubramaniam, Kumaravelu, Grambsch, Patricia M., Wiesner, Russell H., Lindor, Keith D., Dickson, E.Rolland·1990·Gastroenterology

Abstract

Data from 73 asymptomatic patients with primary biliary cirrhosis were analyzed to determine clinical course and long-term survival. Of these, 44 entered a D-penicillamine treatment trial; 29 qualified but chose not to participate. Median follow-up was 7.6 yr (range, 2.8-12.2 yr). Liver biopsy at the initial visit showed advanced disease (fibrosis, cirrhosis) in 61% of the patients. During prospective clinical follow-up, which was available for 37 of the 44 study patients, one or more symptoms of liver disease developed in 33 (89%); esophageal varices were found in 15 (41%), and histologic progression to cirrhosis was found in 20 (67%) of the 30 precirrhotic patients. Significant (p less than 0.01) biochemical progression was reflected by a decrease in mean serum albumin concentrations and an increase in mean serum bilirubin levels in 32 patients followed for 4-6 yr. Survival data were available for all 73 patients; 17 died (11 secondary to liver failure), and 1 underwent liver transplantation. These patients had a 4-fold increase in mortality rate (p less than 0.001) compared with the U.S. population matched for age, race, and sex.

Integrity signals

Registry

Crossref · 10.1016/0016-5085(90)91091-j

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Survival of both symptomatic and asymptomatic patients with PBC is significantly less than that of the general population.

    “More recent studies with longer follow-up indicate that, although asymptomatic disease tends to progress at a much slower rate than symptomatic disease, survival of both symptomatic and asymptomatic patients with PBC is significantly less than that of the general population.125 126”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Balasubramaniam, K., Grambsch, P. M., Wiesner, R. H., Lindor, K. D., & Dickson, E. R.
Affiliations
Mayo Clinic (US)
Venue
Gastroenterology
Publisher
Elsevier BV
Published
1990-06
Volume
98
Issue
6
Pages
1567-1571
ISSN
0016-5085 (ISSN-L)
OpenAlex
W140612521
Cited by
141
References
24
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2018: 7 · 2017: 5 · 2016: 1 · 2014: 1 · 2013: 1 · 2012: 3
FWCI
4.06
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (DK34238 02, R01DK034238)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
primary biliary cirrhosis, asymptomatic patients, long-term survival, mortality, D-penicillamine, disease progression, esophageal varices, liver failure, serum albumin, serum bilirubin, liver transplantation
MeSH terms
Adult, Aged, Bilirubin, Female, Follow-Up Studies, Humans, Liver, Liver Cirrhosis, Biliary, Male, Middle Aged, Penicillamine, Prospective Studies, Serum Albumin, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review